Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Alimera Sciences Q4 EPS $(0.07) Up From $(0.54) YoY, Sales $26.31M Beat $24.34M Estimate

Author: Benzinga Newsdesk | March 07, 2024 08:32am
Alimera Sciences (NASDAQ:ALIM) reported quarterly losses of $(0.07) per share. This is a 87.04 percent increase over losses of $(0.54) per share from the same period last year. The company reported quarterly sales of $26.31 million which beat the analyst consensus estimate of $24.34 million by 8.08 percent. This is a 87.51 percent increase over sales of $14.03 million the same period last year.

Posted In: ALIM

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist